| (USD) | Jun 2019 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -8.26M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SNNAQ returned +0.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.0% |
| 1 year | +0.0% |
| 5 years | -98.7% |
| All-time high | $25.02 (Aug 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SNNAQ would be worth today ›No. Sienna Biopharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Sienna Biopharmaceuticals, Inc. is part of the Healthcare sector.
Sienna Biopharmaceuticals, Inc. has a market cap of 3.09K USD, based on the latest quote.